Tuesday, May 17, 2016

BRIEF-Fitch says drug approvals driving targeted acquisitions in US pharma

* Large innovative U.S. Pharmaceutical companies are

expected to continue targeted acquisitions as need for larger

transactions has declined

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)